The lexis meetings take immense pleasure in announcing the 4th International Conference on Immunity, Immunology, and Immunochemistry on March 15-16, 2023 in Chicago, USA.
The theme of this year‘s meeting is the Role of the Immune System towards Infectious Diseases which provides an international platform for discussion of present and future summons in Advancements of immunology in curing deadly infectious diseases, expertise meeting, and review of research.
Immunology Infectious Diseases 2023 is the perfect platform for the interaction among specialists, directors, professors, medical, and surgical, experts, reputed research institutes, universities, and medical schools and mainly accelerating the worldwide advancements in the sciences of pathology, virology, immunology, and infectious illnesses.
Scope
A very large pharmaceutical pipeline for immunology, consisting of 1, 838 active products is being developed However, it is anticipated that the products in the late-stage pipeline will perform only moderately commercially.
Several key commercially successful products, including Humira and regicide, are due to lose patent protection in the forecast period.
The leading market participants, who are all included within the top 20 pharmaceutical firms, are anticipated to hold onto their position as the market leader during the projection period.
Why attend?
Consider the illness pathophysiology and the diagnostic therapy options that are available at each stage of infection to gain an understanding of the current clinical and industrial landscape.
Envisage the composition of the immunology market across every indication, in terms of dominant targets, highlighting the key commercial assets and players.
Analyze the pipeline of immunology and stratify its development stage, molecular target along with molecule type and with its granular breakdown across key indications
Recognize the expansion of immunology's patient epidemiology and market revenues across all major companies and product categories internationally.
Examine trends in licensing and co-development deals to find immunology industry prospects.
Coronaviruses {Covid-19}
The large family of viruses known as coronaviruses can infect both humans and animals and cause disease. In humans, several coronaviruses are known to cause respiratory infections starting from cold to more severe diseases like Middle East Respiratory Syndrome and Severe Acute Respiratory syndrome. The foremost recently discovered coronavirus disease COVID – 19.
Clinical Immunology & Current & Future Research
The field of science known as immunology deals with the investigation of the immune systems of all living things. The disciplines of cancer, Rheumatology, virology, pathology, microbiology, bacteriology, and dermatology all heavily rely on immunology.
It also includes conditions where the pathophysiology and clinical characteristics of the disease are influenced by immune responses. Immunological aspects of endocrine diseases.
Immunological techniques
Immunological aspects of cardiac diseases.
Immune regulation
Immunological aspects of allergy and anaphylaxis
Immunology of HIV infections
Immune-mediated neurological syndromes
Molecular Immunology
Molecular Immunology deals with the understanding of how the immune system functions and how it is able to protect humans from diseases, such as infections and microscopic organisms. The innocuous or valuable microorganisms in our conditions. Different systems utilized in molecular Immunology Antibodies counteracting agents utilize Elisa, Nephelometry, and Radioimmunology.
Immune signal transduction
Immune calcium signals
Immune protein folding
Immune endocytosis
Cell stress response
Immune cell metabolism
Tumor Immunology
The branch of biology concerned with the role of the immune system in the progression and development of cancer is known as tumor Immunology. The most well know the application is C Cancer Immune Therapy where the immune system is used to treat cancer.
Immunoediting induces selection for certain tumor cells, which lose dominant tumor-specific antigens allowing the tumor to progress. It has 3 main phases: elimination, equilibrium, and escape.
Carcinogenesis
Once genomics
Cancer Immunology & Immunotherapy
Tumor-Associated Antigen & Immunosuppression.
Kindly register here - https://www.lexismeeting.com/immunochemistry/registration